Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
312
312 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- ABC008UlviprubartPhase 33 trials
Abcuro, Inc. · Inclusion Body Myositis (IBM), Inclusion Body Myositis, T-cell Large Granular Lymphocytic Leukemia
- BezuclastinibCGT9486, PLX9486Phase 33 trials
Cogent Biosciences, Inc. · Advanced Systemic Mastocytosis (AdvSM), SM With an Associated Hematologic Neoplasm (SM-AHN), Mast Cell Leukemia (MCL)
- BIVV001efanesoctocog, AltuvoctPhase 33 trials
Swedish Orphan Biovitrum · Haemophilia A (Moderate or Severe), Hemophilia A, Hemophilia A, Severe
- bypassing agentsClotting factor concentrates, CFCPhase 33 trials
Sanofi · Hemophilia, Von Willebrand Disease, Type 3
- CyclophosphamidPhase 33 trials
Alentis Therapeutics AG · Glomerulonephritis Rapidly Progressive, Diffuse Large B-Cell Lymphoma (DLBCL), Metastatic Colorectal Cancer
- ESAErythropoiesis-Stimulating AgentPhase 33 trials
Kind Pharmaceuticals LLC · Anemia Due to Chronic Kidney Disease, Anemia of Chronic Kidney Disease
- FRSW107Phase 33 trials
Hangzhou Gensciences Biopharmaceutical Co., Ltd. · Severe Hemophilia A
- NSC 613327Phase 33 trials
BeBetter Med Inc · Locally Advanced Triple-negative Breast Cancer, Metastatic Triple-negative Breast Cancer, Relapsed/Refractory Diffuse Large B-Cell Lymphoma
- NX-5948bexobrutidegPhase 33 trials
Nurix Therapeutics, Inc. · B-cell Lymphoma, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
- RadotinibSupect, IY5511Phase 33 trials
Il-Yang Pharm. Co., Ltd. · Chronic Myeloid Leukemia, Chronic Phase, CML, Chronic Phase, CML, Refractory
- SG301Phase 33 trials
Hangzhou Sumgen Biotech Co., Ltd. · Systemic Lupus Erythematosus (SLE), Relapsed/Refractory Multiple Myeloma, Antibody Mediated Rejection
- TAK-755rADAMTS13, recombinant ADAMTS13Phase 33 trials
Takeda · Thrombotic Thrombocytopenic Purpura (TTP), Acute Ischemic Stroke
- TirabrutinibONO-4059Phase 33 trials
Ono Pharmaceutical Co., Ltd. · Pemphigus, Steroid-resistant Pemphigus, Relapsed/Refractory Primary Central Nervous System Lymphoma
- TQB2825Phase 33 trials
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. · Follicular Lymphoma, Diffuse Large B Cell Lymphoma, Diffuse Large Cell B-lymphoma
- Zola-celBMS-986353, CC-97540Phase 33 trials
Bristol Myers Squibb · Systemic Sclerosis, Lupus Erythematosus, Systemic, Lupus Nephritis
- Arlocabtagene AutoleucelBMS-986393, GPRC5D CAR T cellsPhase 32 trials
Bristol Myers Squibb · Multiple Myeloma, Relapsed or Refractory Multiple Myeloma (RRMM)
- bb2121BMS-986395Phase 32 trials
Bristol Myers Squibb · Multiple Myeloma
- BCD-248Phase 32 trials
Biocad · Relapsed/Refractory Multiple Myeloma, Myeloma Multiple
- BL-8040Phase 32 trials
BioLineRx, Ltd. · Multiple Myeloma, Pancreatic Adenocarcinoma
- BL-M11D1Phase 32 trials
Sichuan Baili Pharmaceutical Co., Ltd. · Acute Myeloid Leukemia, Myelodysplastic Syndromes
- BleximenibJNJ-75276617Phase 32 trials
Johnson & Johnson (Janssen) · Acute Leukemia, Leukemia, Myeloid, Acute
- ClifutinibHEC73543Phase 32 trials
Sunshine Lake Pharma Co., Ltd. · Leukemia, Acute Myeloid (AML), Acute Myeloid Leukemia, Adult
- CLR 131I-131-CLR1404, Iopofosine I 131 single dosePhase 32 trials
Cellectar Biosciences, Inc. · Waldenstrom Macroglobulinemia, Multiple Myeloma, Chronic Lymphocytic Leukemia
- CobolimabPhase 32 trials
GSK · Melanoma, Hodgkin Lymphoma, High and Low Grade Glioma
- CrenolanibPhase 32 trials
Arog Pharmaceuticals, Inc. · Newly Diagnosed FLT3 Mutated AML, Relapsed/Refractory Acute Myeloid Leukemia With FLT3 Activating Mutations
- DersimelagonMT-7117Phase 32 trials
Tanabe Pharma America, Inc. · EPP, XLP, Erythropoietic Protoporphyria (EPP)
- DISC-1459Bitopertin, RO4917838Phase 32 trials
Disc Medicine, Inc · Erythropoietic Protoporphyria, Erythropoietic Protoporphyria (EPP), X-Linked Protoporphyria (XLP)
- Equecabtagene AutoleucelFUCASOPhase 32 trials
Nanjing IASO Biotechnology Co., Ltd. · Refractory Immune-mediated Necrotizing Myopathy, Multiple Myeloma
- GM-CSFPhase 32 trials
Y-mAbs Therapeutics · Neuroblastoma, Acute Myeloid Leukemia
- GolidocitinibPhase 32 trials
Dizal Pharmaceuticals · T-cell Lymphomas, Peripheral T-cell Lymphoma
- GS1191-0445Phase 32 trials
Gritgen Therapeutics Co., Ltd. · Severe Hemophilia A, Hemophilia A
- HetrombopagPhase 32 trials
Jiangsu HengRui Medicine Co., Ltd. · Chemotherapy-Induced Thrombocytopenia, Immune Thrombocytopenia
- HMPL-306Phase 32 trials
Hutchmed · Acute Myeloid Leukemia, Grade 2 Astrocytoma or Oligodendroglioma With an IDH1 or IDH2 Mutation
- HMPL-523SovleplenibPhase 32 trials
Hutchmed · Warm Antibody Autoimmune Hemolytic Anemia, Primary Immune Thrombocytopenia (ITP)
- HS-10382MK-4208, Tern-701Phase 32 trials
Jiangsu Hansoh Pharmaceutical Co., Ltd. · Chronic Myeloid Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Chronic Myeloid Leukemia, Chronic Phase
- Ifupinostat HydrochlorideBEBT-908, CUDC-908Phase 32 trials
BeBetter Med Inc · Previously Untreated Peripheral T-Cell Lymphoma, Relapsed/Refractory Diffuse Large B-Cell Lymphoma
- KITE-753Phase 32 trials
Gilead Sciences · Relapsed or Refractory Large B-cell Lymphoma, Relapsed and/or Refractory B-cell Lymphoma
- NeladalkibNVL-655Phase 32 trials
Nuvalent Inc. · Non-small Cell Lung Cancer, Anaplastic Lymphoma Kinase-positive, Locally Advanced Solid Tumor
- NXT007Zemocimig, RO7589655Phase 32 trials
Roche (Genentech) · Hemophilia A
- OSE2101Phase 32 trials
OSE Immunotherapeutics · Patients With Non-Small Cell Lung Cancer, Solid Advanced Tumor, Lymphoma
- PORT-77Phase 32 trials
Portal Therapeutics, Inc. · Erythropoietic Protoporphyria (EPP), X-Linked Protoporphyria (XLP), EPP2
- Purinostat MesylatePhase 32 trials
Chengdu Zenitar Biomedical Technology Co., Ltd · Relapsed or Refractory Multiple Myeloma (RRMM), Recurrent and Refractory Diffuse Large B-cell Lymphoma
- QL0911Phase 32 trials
Qilu Pharmaceutical Co., Ltd. · Cancer Treatment-Induced Thrombocytopenia, Thrombocytopenia, Immune
- QLS32015Phase 32 trials
Qilu Pharmaceutical Co., Ltd. · Relapsed or Refractory Multiple Myeloma
- QLS4131Phase 32 trials
Qilu Pharmaceutical Co., Ltd. · Malignant Plasma Cell Neoplasms, Relapsed or Refractory Multiple Myeloma
- RituxumabPhase 32 trials
Roche (Genentech) · Diffuse Large B-cell Lymphoma, DLBCL - Diffuse Large B Cell Lymphoma
- Rondecabtagene autoleucelLYL314Phase 32 trials
Lyell Immunopharma, Inc. · Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma, Non-Hodgkin Lymphoma
- RoxadustatFG-4592, ASP1517Phase 32 trials
Astellas · Chronic Kidney Disease, Renal Anemia, Myelodysplastic Syndromes
- SapablursenISIS 702843, ONO-0530Phase 32 trials
Ono Pharmaceutical Co., Ltd. · Polycythemia Vera, Phlebotomy Dependent Polycythemia Vera
- SoquelitinibCPI-818Phase 32 trials
Corvus Pharmaceuticals, Inc. · Atopic Dermatitis, Atopic Dermatitis Eczema, Eczema
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.